Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Ward, Alejandra ^a   Morettin, Alan ^a   Shum, David ^b   Hudson, John W ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b WINDSOR REGIONAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALCOHOL; DNA; POLO LIKE KINASE; PROTEIN P53; TRICHOSTATIN A; VALPROIC ACID; PLK4 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTROSOME; CONTROLLED STUDY; CPG ISLAND; DNA MODIFICATION; DOWN REGULATION; EMBRYO; EPIGENETICS; FEMALE; FIBROBLAST; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN FAMILY; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEX DIFFERENCE; UPREGULATION; WESTERN BLOTTING; AGING; ANIMAL; CELL CULTURE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AGING; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 79851512476     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-71     Document Type: Article

References (38)

1. Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rubsamen-Waigmann H, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997, 14(5):543-549. 10.1038/sj.onc.1200862, 9053852.
2. Knecht R, Oberhauser C, Strebhardt K. PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas. International Journal of Cancer 2000, 89(6):535-536.
3. Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Polo-like kinases (Plks) and cancer. Oncogene 2005, 24(2):287-291. 10.1038/sj.onc.1208272, 15640844.
4. Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, Lu L, Dai W. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas. J Biol Chem 1996, 271(32):19402-19408. 10.1074/jbc.271.32.19219, 8702627.
5. Dai W, Li Y, Ouyang B, Pan H, Reissmann P, Li J, Wiest J, Stambrook P, Gluckman JL, Noffsinger A, et al. PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer. Genes Chromosomes Cancer 2000, 27(3):332-336. 10.1002/(SICI)1098-2264(200003)27:3<332::AID-GCC15>3.0.CO;2-K, 10679924.
6. Smith P, Syed N, Crook T. Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3. Cell Cycle 2006, 5(12):1262-1264. 10.4161/cc.5.12.2813, 16868416.
7. Ko MA, Rosario CO, Hudson JW, Kulkarni S, Pollett A, Dennis JW, Swallow CJ. Plk4 haplo-insufficiency causes mitotic infidelity and carcinogenesis. Nature Genetics 2005, 37:883-888. 10.1038/ng1605, 16025114.
8. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005, 7(11):1140-1146. 10.1038/ncb1320, 16244668.
9. Petrinac S, Ganuelas ML, Bonni S, Nantais J, Hudson JW. Polo-like kinase 4 phosphorylates Chk2. Cell Cycle 2009, 8(2):327-329. 10.4161/cc.8.2.7355, 19164942.
10. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16(Spec No 1):R50-59. 10.1093/hmg/ddm018, 17613547.
11. Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O'Nions J, Allday M, Hoffmann I, Crawford D, et al. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 2006, 107(1):250-256. 10.1182/blood-2005-03-1194, 16160013.
12. Hayslip J, Montero A. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review. Mol Cancer 2006, 5:44. 10.1186/1476-4598-5-44, 1629025, 17026765.
13. Tischoff I, Tannapfe A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008, 14(11):1741-1748. 10.3748/wjg.14.1741, 2695914, 18350605.
14. Bosch FRJ, Díaz M, Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004, 127(5):S5-S16. 10.1053/j.gastro.2004.09.011, 15508102.
15. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317(5834):121-124. 10.1126/science.1140485, 17615358.
16. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009, 69(1):243-252. 10.1158/0008-5472.CAN-08-2489, 2613548, 19118009.
17. Morettin A, Ward A, Nantais J, Hudson JW. Gene expression pattern in Plk4 heterozygous murine embryonic fibroblasts. BMC Genomics 2009, 10:319. 10.1186/1471-2164-10-319, 2727538, 19607708.
18. Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol 2009, 10(4):265-275. 10.1038/nrm2653, 19305416.
19. Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, Evert M, Dombrowski F, Schirmacher P, Longerich T. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51(3):857-868.
20. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, Thorgeirsson SS. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007, 117(9):2713-2722. 10.1172/JCI31457, 1950459, 17717605.
21. Li J, Tan M, Li L, Pamarthy D, Lawrence TS, Sun Y. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia 2005, 7(4):312-323. 10.1593/neo.04325, 1501148, 15967108.
22. Swallow CJ, Ko MA, Siddiqui NU, Hudson JW, Dennis JW. Sak/Plk4 and Mitotic Fidelity. Oncogene 2005, 24(2):306-312. 10.1038/sj.onc.1208275, 15640847.
23. Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S. Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res 2008, 32(9):1525-1534. 10.1111/j.1530-0277.2008.00729.x, 18616668.
24. Bonsch D, Lenz B, Reulbach U, Kornhuber J, Bleich S. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm 2004, 111(12):1611-1616. 10.1007/s00702-004-0232-x, 15565495.
25. Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J, Bonsch D. Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res 2006, 30(4):587-591. 10.1111/j.1530-0277.2006.00068.x, 16573575.
26. Marsit CJ, McClean MD, Furniss CS, Kelsey KT. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 2006, 119(8):1761-1766. 10.1002/ijc.22051, 16708382.
27. Pani G, Fusco S, Colavitti R, Borrello S, Maggiano N, Cravero AA, Farre SM, Galeotti T, Koch OR. Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice. Biochem Biophys Res Commun 2004, 325(1):97-100. 10.1016/j.bbrc.2004.09.213, 15522206.
28. Hudson JW, Kozarova A, Cheung P, Macmillan JC, Swallow CJ, Cross JC, Dennis JW. Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr Biol 2001, 11(6):441-446. 10.1016/S0960-9822(01)00117-8, 11301255.
29. Rosario CO, Ko MA, Haffani YZ, Gladdy RA, Paderova J, Pollett A, Squire JA, Dennis JW, Swallow CJ. Plk4 is required for cytokinesis and maintenance of chromosomal stability. Proc Natl Acad Sci USA 107(15):6888-6893. 10.1073/pnas.0910941107, 2872425, 20348415.
30. Madesh M, Zong WX, Hawkins BJ, Ramasamy S, Venkatachalam T, Mukhopadhyay P, Doonan PJ, Irrinki KM, Rajesh M, Pacher P, et al. Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak. Mol Cell Biol 2009, 29(11):3099-3112. 10.1128/MCB.01845-08, 2681999, 19332555.
31. Wang LH, Yang JY, Cui W, Shin YK, Wu CF. Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts. Yakugaku Zasshi 2008, 128(7):1067-1071. 10.1248/yakushi.128.1067, 18591875.
32. Hitchler MJ, Domann FE. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med 2009, 47(2):115-127. 10.1016/j.freeradbiomed.2009.04.010, 2728018, 19362589.
33. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008, 135(6):2128-2140. 2140 e2121-2128, 10.1053/j.gastro.2008.07.027, 18801366.
34. Min JY, Lim SO, Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett 584(11):2427-2432. 10.1016/j.febslet.2010.04.048, 20416298.
35. Soriano AO, Yang H, Faderl S, Estrov Z, Giles F, Ravandi F, Cortes J, Wierda WG, Ouzounian S, Quezada A, et al. Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome. Blood 2007, 110(7):2302-2308. 10.1182/blood-2007-03-078576, 17596541.
36. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93(18):9821-9826. 10.1073/pnas.93.18.9821, 38513, 8790415.
37. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18(11):1427-1431. 10.1093/bioinformatics/18.11.1427, 12424112.
38. Jeong KS, Lee S. Estimating the total mouse DNA methylation according to the B1 repetitive elements. Biochem Biophys Res Commun 2005, 335(4):1211-1216. 10.1016/j.bbrc.2005.08.015, 16115613.